Trial Outcomes & Findings for Intergenerational Behavioral Intervention to Enhance Physical Activity in Older Adults at Risk for Alzheimer's Disease (NCT NCT06038643)

NCT ID: NCT06038643

Last Updated: 2025-07-09

Results Overview

This metric quantifies the change in the average number of steps taken each day, from the baseline period to the 4-week period. It is a marker of change in habitual ambulatory activity.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

76 participants

Primary outcome timeframe

4-week

Results posted on

2025-07-09

Participant Flow

Participant milestones

Participant milestones
Measure
Intervention
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
Overall Study
STARTED
36
40
Overall Study
COMPLETED
26
36
Overall Study
NOT COMPLETED
10
4

Reasons for withdrawal

Reasons for withdrawal
Measure
Intervention
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
Overall Study
Withdrawal by Subject
9
4
Overall Study
Excluded (not longer fulfilled enrollment criteria)
1
0

Baseline Characteristics

Intergenerational Behavioral Intervention to Enhance Physical Activity in Older Adults at Risk for Alzheimer's Disease

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Intervention
n=26 Participants
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
n=36 Participants
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
Total
n=62 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
4 Participants
n=5 Participants
4 Participants
n=7 Participants
8 Participants
n=5 Participants
Age, Categorical
>=65 years
22 Participants
n=5 Participants
32 Participants
n=7 Participants
54 Participants
n=5 Participants
Age, Continuous
69.81 years
STANDARD_DEVIATION 4.32 • n=5 Participants
70.97 years
STANDARD_DEVIATION 5.36 • n=7 Participants
70.48 years
STANDARD_DEVIATION 4.95 • n=5 Participants
Sex: Female, Male
Female
15 Participants
n=5 Participants
29 Participants
n=7 Participants
44 Participants
n=5 Participants
Sex: Female, Male
Male
11 Participants
n=5 Participants
7 Participants
n=7 Participants
18 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
26 Participants
n=5 Participants
36 Participants
n=7 Participants
62 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
White
25 Participants
n=5 Participants
36 Participants
n=7 Participants
61 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
Canada
26 participants
n=5 Participants
36 participants
n=7 Participants
62 participants
n=5 Participants
Years of Education
16.08 years
STANDARD_DEVIATION 3.07 • n=5 Participants
15.97 years
STANDARD_DEVIATION 3.55 • n=7 Participants
16.02 years
STANDARD_DEVIATION 3.33 • n=5 Participants
APOE4 genotype
APOE4 carriers
8 Participants
n=5 Participants
16 Participants
n=7 Participants
24 Participants
n=5 Participants
APOE4 genotype
APOE4 non-carriers
18 Participants
n=5 Participants
20 Participants
n=7 Participants
38 Participants
n=5 Participants
Body Mass Index
27.39 kg/m²
STANDARD_DEVIATION 5.03 • n=5 Participants
26.48 kg/m²
STANDARD_DEVIATION 4.56 • n=7 Participants
26.86 kg/m²
STANDARD_DEVIATION 4.74 • n=5 Participants
Alzheimer's Disease Risk
Lower Risk
18 Participants
n=5 Participants
19 Participants
n=7 Participants
37 Participants
n=5 Participants
Alzheimer's Disease Risk
Higher Risk
8 Participants
n=5 Participants
17 Participants
n=7 Participants
25 Participants
n=5 Participants
Mild Cognitive Impairment
Mild Cognitive Impairment
6 Participants
n=5 Participants
6 Participants
n=7 Participants
12 Participants
n=5 Participants
Mild Cognitive Impairment
Cognitively Unimpaired
20 Participants
n=5 Participants
30 Participants
n=7 Participants
50 Participants
n=5 Participants
Language
English
4 Participants
n=5 Participants
5 Participants
n=7 Participants
9 Participants
n=5 Participants
Language
French
22 Participants
n=5 Participants
31 Participants
n=7 Participants
53 Participants
n=5 Participants
Diastolic Blood Pressure
74.69 mmHg
STANDARD_DEVIATION 8.14 • n=5 Participants
74.42 mmHg
STANDARD_DEVIATION 6.58 • n=7 Participants
74.53 mmHg
STANDARD_DEVIATION 7.21 • n=5 Participants
Systolic Blood Pressure
125.81 mmHg
STANDARD_DEVIATION 16.36 • n=5 Participants
128.22 mmHg
STANDARD_DEVIATION 14.79 • n=7 Participants
127.21 mmHg
STANDARD_DEVIATION 15.38 • n=5 Participants
Steps per day
4224.77 Steps/day
STANDARD_DEVIATION 3149.72 • n=5 Participants
3881.07 Steps/day
STANDARD_DEVIATION 2978.81 • n=7 Participants
4025.20 Steps/day
STANDARD_DEVIATION 3051.94 • n=5 Participants
TMB Serial Reaction Time
364.73 seconds
STANDARD_DEVIATION 74.73 • n=5 Participants
388.13 seconds
STANDARD_DEVIATION 103.15 • n=7 Participants
378.54 seconds
STANDARD_DEVIATION 92.6 • n=5 Participants
TMB Choice Reaction Time
1208.83 seconds
STANDARD_DEVIATION 327.14 • n=5 Participants
1304.72 seconds
STANDARD_DEVIATION 639.63 • n=7 Participants
1265.42 seconds
STANDARD_DEVIATION 532.66 • n=5 Participants
Test my Brain Gradual Onset Continuous Performance Test (C)
0.38 Score on a scale
STANDARD_DEVIATION 0.43 • n=5 Participants
0.33 Score on a scale
STANDARD_DEVIATION 0.43 • n=7 Participants
0.35 Score on a scale
STANDARD_DEVIATION 0.43 • n=5 Participants
TMB Gradual Onset Continuous Performance Test (D)
2.71 scores on a scale
STANDARD_DEVIATION 0.77 • n=5 Participants
2.58 scores on a scale
STANDARD_DEVIATION 0.96 • n=7 Participants
2.64 scores on a scale
STANDARD_DEVIATION 0.88 • n=5 Participants
Test my Brain Matrix Reasoning
21.4 Score on a scale
STANDARD_DEVIATION 7.8 • n=5 Participants
21.14 Score on a scale
STANDARD_DEVIATION 6.8 • n=7 Participants
21.25 Score on a scale
STANDARD_DEVIATION 7.17 • n=5 Participants
Test my Brain Forward Digit Span
6.84 Score on a scale
STANDARD_DEVIATION 1.57 • n=5 Participants
6.0 Score on a scale
STANDARD_DEVIATION 1.99 • n=7 Participants
6.35 Score on a scale
STANDARD_DEVIATION 1.86 • n=5 Participants
Test my Brain Backwards Digit Span
5.28 Score on a scale
STANDARD_DEVIATION 1.88 • n=5 Participants
4.94 Score on a scale
STANDARD_DEVIATION 1.76 • n=7 Participants
5.08 Score on a scale
STANDARD_DEVIATION 1.81 • n=5 Participants
Test my Brain Visual Paired Associates Matching
14.5 Score on a scale
STANDARD_DEVIATION 4.3 • n=5 Participants
14.9 Score on a scale
STANDARD_DEVIATION 4.3 • n=7 Participants
14.73 Score on a scale
STANDARD_DEVIATION 4.3 • n=5 Participants
Test my Brain Digit Symbol Matching
36 Score on a scale
STANDARD_DEVIATION 6.95 • n=5 Participants
35.53 Score on a scale
STANDARD_DEVIATION 8.85 • n=7 Participants
35.72 Score on a scale
STANDARD_DEVIATION 8.06 • n=5 Participants

PRIMARY outcome

Timeframe: 4-week

Population: Participants included in the analysis were those who completed the study.

This metric quantifies the change in the average number of steps taken each day, from the baseline period to the 4-week period. It is a marker of change in habitual ambulatory activity.

Outcome measures

Outcome measures
Measure
Intervention
n=26 Participants
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
n=36 Participants
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
Total Step Count (Average Steps/Day)
5648.91 Steps/day
Standard Deviation 4033.49
3809.62 Steps/day
Standard Deviation 2833.25

SECONDARY outcome

Timeframe: 4 weeks

The Modified Differential Emotions Scale (mDES) Negative Emotions subscale measures the intensity of negative emotional experiences such as sadness, anger, fear, and shame. Possible scores: min. 0, max. 80 A higher score indicates greater emotional intensity or frequency of the emotions assessed.

Outcome measures

Outcome measures
Measure
Intervention
n=23 Participants
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
n=31 Participants
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
The Modified Differential Emotions Scale (mDES) Negative Emotions
1.18 score
Standard Deviation 0.27
1.31 score
Standard Deviation 0.37

SECONDARY outcome

Timeframe: 4 weeks

Population: Participants included in the analysis were those who completed the Generativity questionnaire.

This questionnaire measures generativity, which refers to the concern or desire individuals have to contribute to the well-being and development of future generations. Generative evaluates the extent to which individuals are motivated by generative concerns, including the desire to impact others and future generations; the Achievement subscale specifically captures the orientation toward personal goal attainment, mastery, and the pursuit of success as expressions of generativity. Scores for the generative achievement subscale ranged between 6 and 36, with higher scores indicating greater generative achievement.

Outcome measures

Outcome measures
Measure
Intervention
n=21 Participants
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
n=29 Participants
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
Generativity - Achievement
25.09 score
Standard Deviation 5.18
22.58 score
Standard Deviation 5.88

SECONDARY outcome

Timeframe: 4 weeks

Population: The population included in the analysis were those who completed the Test My Brain Backward Digit Span subtest.

The TestMyBrain Digital Neuropsychology Toolkit Backwards Digit Span assesses working memory by requiring individuals to recall sequences of numbers in reverse order. In the backward version, the participant is shown a series of numbers in increasing length and asked to recall the numbers in reverse order. This is a test of short-term memory and working memory. This test was adapted from the Wechsler Adult Intelligence Scales. Scores go from 1 to 10. Higher scores are better.

Outcome measures

Outcome measures
Measure
Intervention
n=24 Participants
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
n=28 Participants
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
Test My Brain Digital Neuropsychology Toolkit - Backwards Digit Span
6.58 score
Standard Deviation 1.53
4.89 score
Standard Deviation 1.83

SECONDARY outcome

Timeframe: 4 weeks

University of California, Los Angeles (UCLA) Loneliness Scale. A higher average score indicates greater loneliness. Possible scores: min. 20, max. 80.

Outcome measures

Outcome measures
Measure
Intervention
n=26 Participants
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
n=36 Participants
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
Loneliness
53.71 score
Standard Deviation 23.89
44.87 score
Standard Deviation 19.25

SECONDARY outcome

Timeframe: 4 weeks

The Modified Differential Emotions Scale (mDES) Positive Emotions subscale measures the intensity of positive emotional experiences such as joy, gratitude, love, and hope. Possible scores: min. 0, max. 80 A higher score indicates greater emotional intensity or frequency of the emotions assessed.

Outcome measures

Outcome measures
Measure
Intervention
n=23 Participants
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
n=31 Participants
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
Modified Differential Emotions Scale (mDES) Positive Emotions
3.38 score
Standard Deviation 0.69
3.40 score
Standard Deviation 0.75

SECONDARY outcome

Timeframe: 4 weeks

Population: Participants included in the analysis had completed the Generativity questionnaire.

The Generative Test measures generativity, which refers to the concern or desire individuals have to contribute to the well-being and development of future generations. The Desire subscale specifically assesses the emotional motivation and intrinsic longing to nurture, support, and positively impact others and future generations. Scores for the generative desire subscale ranged between 7 and 42, with higher scores indicating greater generative desire.

Outcome measures

Outcome measures
Measure
Intervention
n=21 Participants
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
n=29 Participants
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
Generativity Desire
31.67 score
Standard Deviation 6.13
29.72 score
Standard Deviation 7.05

SECONDARY outcome

Timeframe: 4 weeks

Population: The population included in the analysis was those who completed the Test My Brain Choice Reaction Time.

The TestMyBrain Digital Neuropsychology Toolkit Choice Reaction Time task measures processing speed and attention by assessing how quickly individuals respond to different stimuli.

Outcome measures

Outcome measures
Measure
Intervention
n=21 Participants
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
n=29 Participants
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
Test My Brain Digital Neuropsychology Toolkit - Choice Reaction Time
1293.08 seconds
Standard Deviation 722.89
1136.67 seconds
Standard Deviation 389.61

SECONDARY outcome

Timeframe: 4 weeks

Population: Participants included in the analysis had completed the Test My Brain Digit Symbol Matching subtest.

The TestMyBrain Digital Neuropsychology Toolkit Digit Symbol Matching task measures processing speed, attention, and visual-motor coordination by requiring rapid matching of symbols to corresponding numbers.

Outcome measures

Outcome measures
Measure
Intervention
n=20 Participants
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
n=28 Participants
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
Test My Brain Digital Neuropsychology Toolkit - Digit Symbol Matching
38.81 score
Standard Deviation 7.14
36.83 score
Standard Deviation 7.85

SECONDARY outcome

Timeframe: 4 weeks

Population: The population included in the analysis was those who completed the Forward Digit Span.

The TestMyBrain Digital Neuropsychology Toolkit Forward Digit Span task measures short-term memory by requiring individuals to recall sequences of numbers in the order presented. In the forward version of TMB Digit Span, the participant is shown a series of numbers in increasing length and asked to recall the numbers in the order displayed. This is a test of short-term memory. This test was adapted from the Wechsler Adult Intelligence Scales. Scores go from 1 to 11. Higher scores are better.

Outcome measures

Outcome measures
Measure
Intervention
n=21 Participants
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
n=28 Participants
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
Test My Brain Digital Neuropsychology Toolkit - Forward Digit Span
6.91 score
Standard Deviation 1.57
6.18 score
Standard Deviation 1.81

SECONDARY outcome

Timeframe: 4 weeks

Population: The population included in the analysis was those who completed the Test My Brain Gradual Onset Continuous Performance C subtest.

The TestMyBrain Digital Neuropsychology Toolkit Gradual Onset Continuous Performance Task measures sustained attention and inhibitory control by requiring individuals to detect target stimuli amid gradually changing non-targets. In this go/no-go test, the participant presses a button for each city image and withholds button presses for mountain images. This is a test of cognitive control, sustained attention, and response inhibition. Values can be from -1.5 to +1.5. Higher scores indicate better performance. The CPT.C score is a measure of response criterion, or how quickly and/or impulsively the participant tended to respond. Higher scores represent greater response impulsivity.

Outcome measures

Outcome measures
Measure
Intervention
n=21 Participants
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
n=29 Participants
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
Test My Brain Digital Neuropsychology Toolkit - Gradual Onset Continuous Performance C
0.45 score
Standard Deviation 0.25
0.40 score
Standard Deviation 0.36

SECONDARY outcome

Timeframe: 4 weeks

Population: The population included in the analysis was those who completed the Test My Brain Gradual Onset Continuous Performance D subtest.

The TestMyBrain Digital Neuropsychology Toolkit Gradual Onset Continuous Performance Task (D) assesses sustained attention and response inhibition by requiring individuals to monitor and respond to target stimuli within a dynamic visual stream. In this go/no-go test, the participant presses a button for each city image and withholds button presses for mountain images. This is a test of cognitive control, sustained attention, and response inhibition. The CPT.D score is a measure of discrimination performance, related to how accurately the participant was able to respond to mountains and scenes. Higher scores represent better performance. Values can be from 1 to 4. Higher scores indicate better performance.

Outcome measures

Outcome measures
Measure
Intervention
n=21 Participants
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
n=29 Participants
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
Test My Brain Digital Neuropsychology Toolkit - Gradual Onset Continuous Performance D
2.80 score
Standard Deviation 0.65
2.87 score
Standard Deviation 0.91

SECONDARY outcome

Timeframe: 4 weeks

Population: The population included in the analysis was those who completed the Test My Brain Matrix Reasoning.

The TestMyBrain Digital Neuropsychology Toolkit Matrix Reasoning task measures abstract reasoning and fluid intelligence by requiring individuals to identify patterns and complete visual matrices. In Test my Brain Matrix Reasoning, the participant selects which smaller image completes the pattern in the larger image. This is a test of visual reasoning and general cognitive ability. This test was adapted from the Wechsler Adult Intelligence Scales. Scores go from 2 to 32. Higher scores are better.

Outcome measures

Outcome measures
Measure
Intervention
n=21 Participants
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
n=28 Participants
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
Test My Brain Digital Neuropsychology Toolkit - Matrix Reasoning
22.18 score
Standard Deviation 6.52
22.58 score
Standard Deviation 6.04

SECONDARY outcome

Timeframe: 4 weeks.

Population: The population included in the analysis was those who completed the Test My Brain Serial Reaction Time.

The TestMyBrain Digital Neuropsychology Toolkit Serial Reaction Time task measures implicit learning and motor sequence acquisition by assessing response speed to repeating and random stimulus patterns. In the TMB Serial Reaction Time task, higher scores in seconds (i.e., longer reaction times) indicate: Reduced processing speed Lower motor or attentional efficiency Weaker implicit sequence learning

Outcome measures

Outcome measures
Measure
Intervention
n=21 Participants
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
n=29 Participants
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
Test My Brain Digital Neuropsychology Toolkit - Serial Reaction Time
333.24 seconds
Standard Deviation 60.57
384.62 seconds
Standard Deviation 96.47

SECONDARY outcome

Timeframe: 4 weeks

Population: The population included in the analysis was those who completed the Test My Brain Visual Paired Associates.

The TestMyBrain Digital Neuropsychology Toolkit Visual Paired Associates task measures associative memory by requiring individuals to learn and recall visual symbol pairs. In this test, the participant memorizes a set of picture pairs. Then, after completing TMB Digit Symbol Matching (90 sec), the participant selects which pictures were paired together. TMB Visual PA is a test of visual episodic memory. In TMB Digit SM, the participant matches as many number/symbol pairs as possible in 90 seconds. This is a test of processing speed. Scores go from 4 to 23. Higher scores are better.

Outcome measures

Outcome measures
Measure
Intervention
n=21 Participants
Social motivation intervention, self-transcendence daily messages, and daily accelerometry. Motivational behavioural intervention and daily activities monitoring: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Active Control
n=28 Participants
Daily accelerometry. Active Control: Daily activities monitored through accelerometry.
Test My Brain Digital Neuropsychology Toolkit - Visual Paired Associates
16.2 score
Standard Deviation 4.41
16.3 score
Standard Deviation 3.93

Adverse Events

Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Active Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Maiya R. Geddes

McGill University

Phone: 514-398-8751

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place